During the COVID-19 pandemic era, pediatric bronchiolitis hospitalizations decreased transiently, then increased, according to a study published online Oct. 26 in JAMA Network Open. Kailey A. Remien, ...

Transitioning from an intensive care unit (ICU)-only high-flow nasal cannula (HFNC) protocol to a weight-based non-ICU HFNC protocol was associated with reduced ICU admission rates for hospitalized ...

Bronchiolitis remains a leading cause of hospitalisation among infants and young children, prompting continuous efforts to optimise management strategies. Recent clinical approaches focus on ...

This review describes the current understanding of bronchiolitis, including the increasing number of viruses that are known to cause it, the current understanding of its pathogenesis, the importance ...

This new research sheds light on the importance of follow-up meetings for young patients discharged from emergency departments (EDs). These new findings and more resulted from a recent retrospective ...

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis. This is the result of a study involving the Università Cattolica del Sacro Cuore, Rome ...

Implementation of bronchiolitis guidelines for infants is associated with significant reductions in the use of emergency department resources, according to findings from a new study. Ayobami Akenroye, ...

This new data suggests that hospital facilities in the US may need to plan for potentially atypical timing of bronchiolitis season once more for 2023. To assess pattern changes since the pandemic ...

Although use of pulse oximetry in hospitalized children with respiratory infections is common, the data supporting its use are limited. Recommendations from the American Academy of Pediatrics in 2006 ...

After a 2022/2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on ...